Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
287K
-
Shares change
-
+38.9K
-
Total reported value, excl. options
-
$450K
-
Value change
-
+$55.9K
-
Number of buys
-
4
-
Number of sells
-
-2
-
Price
-
$1.57
Significant Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q4 2019
13 filings reported holding ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock as of Q4 2019.
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 287K shares
of 129M outstanding shares and own 0.22% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (121K shares), GEODE CAPITAL MANAGEMENT, LLC (89.9K shares), RENAISSANCE TECHNOLOGIES LLC (26.2K shares), Virtu Financial LLC (14.7K shares), Federation des caisses Desjardins du Quebec (13K shares), NORTHERN TRUST CORP (12.5K shares), Ahrens Investment Partners LLC (10K shares), DEUTSCHE BANK AG\ (6.39K shares), UBS Group AG (6K shares), and BlackRock Inc. (615 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.